Q&A: Rentschler’s CEO On The CDMO’s Pivot Away From Cell And Gene Therapy And More

 
• By David Wild
  
Benedikt von Braunmühl
Benedikt von Braunmühl, CEO, Rentschler Biopharma (Rentschler)
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Manufacturing Focus

More from Leadership